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Context: This article discusses the role of data in the reform of the U.S. healthcare system by
focusing on electronic health records (EHRs) and the role of stakeholders.
Evidence acquisition: Review of research published between 2005 and 2012 was conducted in
2012.
Evidence synthesis: Published literature supports the benefıt of information technology in the
healthcare fıeld. Interoperability among systems is deemed key to successful use. However,
incorporating information technology into medical practice will require methodically revamp-
ing the system, and consumers will need to learn how to use and manage their personal medical
records. The healthcare industry’s use of data-driven innovation needs to be based on modern-
ized data systems, increased access to data, and implementation of easy-to-use technology that
will enable stakeholders to participate actively in achieving desired health outcomes and cost
reductions.
Conclusions: Stakeholders realize the power and potential benefıt of data. Access to data and
incentives to develop and adopt them must be supported to achieve cost-savings. However, serious
challenges remain to achieving a national, interoperable system that provides healthcare data to all
stakeholders. These challenges can be addressed only by innovation.
(Am J Prev Med 2013;44(1S1):S5–S11) © 2013 American Journal of Preventive MedicineContext
Dataare critical to decisionmaking anddrive busi-ness strategy at large in today’s fast-paced world.Introduction of electronic health records (EHRs)
n the healthcare system is leading to great expectations
or all stakeholders. They anticipate a broadly accessible,
nteroperable system improved through continuous in-
ovation necessary for serious healthcare reform. Still,
everal challenges remain that could slow the implemen-
ation of such a system.Although datamay provide better
ducation and understanding, decisions based on those
ata will still need to be made by each stakeholder. This
rticle attempts to continue the discussion on the role of
ata in healthcare reform by focusing on EHRs and the
hallenges stakeholders will encounter when implement-
ng systems and performing data analysis.
Discussions on themandate for EHRs have taken place
t all stages of implementation. The costs and the process
f ensuring interoperability among systems have been
oremost concerns. In 2005, Hillestead and colleagues1
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health information technology (HIT) versus the use of
information technology in other industries. After weigh-
ing the costs and benefıts of EHR implementation, they
concluded that the process could save more than
$81 billion annually by improving healthcare effıciency
and safety. In addition, data-enabled prevention andman-
agement of chronic disease potentially may double those
savings. Still, thesedevelopmentswill require further change
in the healthcare model. The authors advocate for vigilant
commitment to the interoperability of data systems.
Similarly, in a Journal of Business and Economics Re-
search article in 2008,2 Paul and Ann Carruth agree with
the need for an interoperable data system. They discuss
the benefıts of such a system that can be accrued by
various stakeholders and highlight how integrated pa-
tient- and population-level data may lead to personalized
medicine. However, they warn that existing challenges
will require long-term commitment to implementation.
They conclude by noting that altering the traditions of
medical practice to incorporate health information tech-
nology will require a methodic revamping of the current
system. Consumers will need to understand the informa-
tion and learn how to electronically manage their per-
sonal medical records.
ier Inc. Am J Prev Med 2013;44(1S1):S5–S11 S5
t
c
r
m
c
m
t
p
p
c
M
c
a
e
r
s
n
c
i
t
h
a
m
n
S6 Meier / Am J Prev Med 2013;44(1S1):S5–S11Evidence Acquisition
Innovation Needed in Capture, Analysis, and
Dissemination of Data
Central tomost initiatives aimed at lowering the cost of health care
are capture, analysis, and dissemination of data. Data, in this case,
extend beyond EHRs and can include any relevant, correct, fre-
quently updated information that would have an impact on the
perception of healthcare quality, outcome, and cost. Data can in-
clude information related to price per procedure, average number
of days spent in the hospital per procedure, and other information
that helps consumers and practitioners evaluate the quality of care
and make cost comparisons. For example, a tradeoff might exist
between procedures that cost less but lead to longer hospital stays
versus those with shorter stays that cost more. One way of evaluat-
ing which is better is to determine which approach is cheaper when
all costs (e.g., procedure, hospital stay) are considered.
The healthcare industry has lagged behind most American enter-
prises in implementing systems that can provide real-time data to its
increasingly consumer-minded customers and has not yet fully em-
braced technology to engage stakeholders in health promotion and
disease prevention.3 Accordingly, a gap exists between understanding
he costs associated with delivering care and how that care and those
osts are associated with medical outcomes. The basis of healthcare
eform should be rooted not only in accumulation of data but,
ore importantly, how the data are used. Thismeans that the health-
are industry’s use of data-driven innovation needs to be based on
odernized data systems, increased access to data, and implementa-
ion of easy-to-use technology that will allow stakeholders to partici-
ate in achieving desired health outcomes and cost reductions.4
The Health Information Technology for Economic and Clinical
Health (HITECH) Act of 2009 permits the DHHS to establish pro-
grams to improvehealthcarequality, safety, andeffıciency through the
adoption of health information technology, including EHRs and pri-
vate, secure electronic health information exchange.5 Still, the antici-
ation and implementation of EHRs have created debate concerning
ost andhowtoensure interoperability amongdifferingEHRsystems.
oreover, there is apprehension that the availability of data without a
orresponding means to conduct real-time analysis of those data will
ctually slow the healthcare delivery process.6
First, the increased capture of data through advanced EHRs is a
long-overdue requirement for advancement in health care, yet it pres-
ents a challenge for providers.7 Although EHRs seem to promise an
xtensive list of benefıts, the inherent risk and fınancial expenditure
equired to implement them are often absent from the conversation.7
Other important concerns relate to data privacy:Whowill be allowed
access towhich type(s) of data; why; and underwhat conditions?And
howwill this access bemanaged securely by the system?
Despite assistance from the government, small and rural hospi-
tals may have to spend a few million dollars to buy and install new
technology; larger hospitals may have to spend much more.8 But
the smaller institutions with lesser resources may not have suffı-
cient volumes of patients to offset the initial investment spent in
fınancing and implementation. The time frame may be too long
between initial outlay and when such hospitals begin to realize
savings from the investment, which is likely to delay the needed
investment. However, over the long term, advanced data capture
can improve healthcare effectiveness and effıciency through better
resource allocation and reduction in errors.7 Therefore, the poten- ptial to recoup the investment in a reasonable amount of time seems
promising, especially for larger hospitals that havemore resources.
Second, as hospitals and physicians increasingly implement EHRs, a
lack of interoperability may prevent systems from communicating with
eachother.2Consequently, thereisconcern,butalsohope, thatauniversal
strategywill be implemented that all stakeholders can adopt.2 It has been
uggested that vendors integrate EHRs by following the “network-of-
etworks” model used by the banking industry in which banks allow
ustomers to access ATMs (and their accounts) from a variety of
nstitutions.7
Beyond the technical issues, which often dominate the discus-
sion about design and implementation, government and other
important stakeholders also need to research and understand so-
cial, political, and clinical challenges thatwill determine the success
or failure of an interoperable system.9 Specifıcally, questions re-
garding governance (i.e., control over who owns, manages, and
consumes the data) need to be addressed.9
Evidence Synthesis
Benefits of Data: Better Care and Financial
Savings
TheuseofEHRsandadvanceddata capturehas alreadybegun
to bear fruit. These methods hold promise for increased
physician–patient interaction,better trackingof thechronically
ill, and real-time exchange andanalysis of data.Asmore stake-
holders implementEHRs, themoreeffective thedataexchange
and themore useful the data will be, enhancing patient care.10
Because of their potential value, since 2008, the use of EHRs
among offıce-based physicians, now at 34%, has nearly dou-
bled; 35% of hospitals have adopted EHRs.10 Further, more
han110,000 eligible professionals andmore than2400 eligible
ospitals have been paid $5.7 billion since 2011 by Medicare
ndMedicaidEHR incentive programs.11
Moreover, in a 2008 study, Palacio and colleagues7 found
that early adoption of healthcare information technology is
associated with improved fınancial performance. Specifıcally,
healthcare organizations with higher use of information tech-
nologyhaveincreasedrevenueandprofıtabilitybecauseofcost-
savings from improved effıciency and reduction in errors.7
(Still, the study warns that the data must complement clinical
andbusiness processes, or the benefıts could be limited.)
Another advantage of EHRs is to provide data that can
be used in comparative-effectiveness research (CER), a
promising method to assess the relative value of treat-
ments. (This is one of the major reasons the government
is helping subsidize the rollout of EHRs.) Specifıcally, this
research can pinpoint treatments that are less effective for
a given condition and influence stakeholders to avoid
prescribing or paying for an approach that is not a good
value overall.12 Accordingly, CER can move into areas of
edical uncertainty such as preventive services and tech-
ology in order to identify patterns and then develop the
olicies that influence them.
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Withmultiple federalmandates concerning data capture,
the healthcare industry is entering a new era not only
driven bydata but shaped by it. Standards andpractices of
EHRs will stabilize so that EHRs become more reliably
interoperable, thus allowing stakeholders to study popu-
lations across various scenarios.12 In this context, data
capture will become the basis for informed, real-time
patient care. Specifıcally, real-time data will allow provid-
ers to track patients and address their immediate needs.
To help stakeholders maximize the potential of a ro-
bust data system requires addressing two broad chal-
lenges. The fırst is how to provide general access to the
data. This will require addressing many issues pertaining
to patient privacy and data security.13 Specifıcally, the
rivacy threat posed by the interoperability of a national
etwork is a key concern, as a great number and variety of
eople and organizations, including those with compet-
ng interests, are likely to want access.13 Consequently, a
reach of privacy is likely to be only amatter of time. This
ssue is a substantial barrier to the adoption of EHRs and
equires accountability among all stakeholders involved
n creating, storing, analyzing, and sharing data.
The next challenge will be to determine appropriate reg-
lation.For example,howwill it bedeterminedwhich stake-
olders can or cannot access relevant data, and under what
onditions?Many businesseswill be eager to profıt from the
eleaseofdata, so this issue is likely tobecomecontentious in
he days ahead. For the protection of all, regulation and
iability must be exceptionally clear on this matter.
Impact on Stakeholders of an Interoperable
System
Patients. Evidence increasingly suggests the cost-’
ffectiveness of self-care and patient engagement.14Mod-
ern consumer-patients want personalized medicine and
increasingly have employed technology platforms to
achieve their goals. Moreover, patient use of data about
medical conditions, recommended courses of treatment,
and prices of services can have a tremendous impact on
healthcare costs.
Physicians. These stakeholders, whose influence is of-
ten underestimated in the context of controlling health-
care costs, can have a great effect if empowered to make
value-based decisions that provide better outcomes and
lower costs. Information technologies have made it con-
siderably easier to deliver high-quality care in the face of
complex medical conditions by providing critical refer-
ence and decision support at the point of care.6
Payers. Health plans and health services companies can
lay a vital role in shaping healthcare reform by working
ith communities, employers, health professionals, hos-
January 2013pitals, and individual consumers to modernize health
promotion and disease prevention initiatives that im-
prove health outcomes and lowermedical care costs.3 Key
to achieving prevention goals will be innovation and
competence in organizing data fromprovider visits, turn-
ing it into actionable knowledge, and applying it at the
right time to the right people in the right formats for
optimal decision making by all concerned.3
Private industry. This stakeholder is very well aware of
the continued rise of healthcare costs because of their sub-
stantial impact on the corporate bottom line. Moreover,
potential legislation is likely to increase the responsibility of
industry with respect to the health care of its employees.15
Industry has responded to these pressures by creating inno-
vative wellness programs, which rely on the kinds of data
systems described here. These programs produce the dual
benefıt of improving employee health/morale and reducing
the corporate cost of health care per employee.
Government. The federal role in health care has ex-
panded over the years and is likely to be a major factor in
the success or failure of healthcare reform in achieving
higher-quality care and better value. Federal leadership
can serve as a powerful “driver” of improvement in
healthcare quality and value, particularly with respect to
prevention and health promotion.16 Whether federal ef-
orts will succeed is arguable but, without them, national
rogress seems unlikely.16
Entrepreneurs. This important stakeholder group
plays the key role of connecting the dots between avail-
able data and stakeholders who will use the data to pro-
mote community health and disease prevention. More-
over, new technologies can extend the scope of medicine
to conditions once considered beyond its boundaries.17
(Table 1 provides an overviewof all the studies referenced
in this article.)
Conclusion
Stakeholders realize and want to take better advantage of
the benefıts and power of data—with their associated
potential to enhance prevention and, in turn, increase
value. Accordingly, to achieve cost-savings, access to data
and incentives to develop and adopt information tech-
nology must be supported.
The mandate for EHRs will transform how the health-
care model functions and can affect the unsustainable
trajectory of healthcare spending for the better. However,
several challenges remain before the U.S. can realize an
interoperable system and its inherent benefıts. These
challenges, and thus the future of the healthcare model,
lie in the hands of innovative stakeholders.
Table 1. Overview of included studies
Study Title Overview of main study points
Tuckson (2003)3 A Role for Payers: Remarks on the Use of Data and Analytics
in Support of Preventive Care
The healthcare industry has lagged behind most American enterprises in
implementing systems that can provide real-time data to its increasingly
consumer-minded customers and has not yet fully embraced technology to
engage stakeholders in health promotion and disease prevention.
Straube (2013)16 A Role for Government: An Observation on Federal
Healthcare Efforts in Prevention
The federal role in health care has expanded over the years and is likely to be a
major factor in the success or failure of healthcare reform in achieving higher-
quality care and better value.
Federal leadership can serve as a powerful “driver” of improvement in
healthcare quality and value, particularly with respect to prevention and health
promotion.
Center for Medicare and
Medicaid Services
(2012)5
EHR Incentive Program The Health Information Technology for Economic and Clinical Health (HITECH)
Act of 2009 permits the DHHS to establish programs to improve healthcare
quality, safety, and efficiency through the adoption of health information
technology, including EHRs and private, secure electronic health information
exchange.
Emanuel (2012)10 An Unsung Victory in Healthcare As more stakeholders implement EHRs, the more effective the data exchange
and the more useful the data will be, enhancing patient care.
Because of their potential value, since 2008, the use of EHRs among office-
based physicians, now at 34%, has nearly doubled; 35% of hospitals have
adopted EHRs.
Center for Medicare and
Medicaid Services
(2012)11
Press Releases: More Than 100,000 Health Care Providers
Paid for Using Electronic Health Records
More than 110,000 eligible professionals and more than 2400 eligible
hospitals have been paid $5.7 billion since 2011 by Medicare and Medicaid
EHR incentive programs.
Sinaiko (2011)6 Increased Price Transparency in Health Care—Challenges
and Potential Effects
The anticipation and implementation of EHRs have created debate concerning
cost and how to ensure interoperability among differing EHR systems.
There is apprehension that the availability of data without a corresponding
means to conduct real-time analysis of those data will actually slow the
healthcare delivery process.
Accenture (2011)9 Providing the Right Foundation Will Make or Break E-health
Reform
Beyond the technical issues, which often dominate the discussion about design
and implementation, government and other important stakeholders also need
to research and understand social, political, and clinical challenges that will
determine the success or failure of an interoperable system. Specifically,
questions regarding governance (i.e., control over who owns, manages, and
consumes the data) need to be addressed.
Lewis (2011)13 Electronic Health Records Face Many Insider Snoops To help stakeholders maximize the potential of a robust data system requires
addressing two broad challenges. The first is how to provide general access
to the data. This will require addressing many issues pertaining to patient
privacy and data security.
Specifically, the privacy threat posed by the interoperability of a national
network is a key concern, as a great number and variety of people and
organizations, including those with competing interests, are likely to want
access.
(continued on next page)
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Table 1. (continued)
Study Title Overview of main study points
Henke (2011)14 Recent Experience in Health Promotion at Johnson &
Johnson: Lower Health Spending, Strong Return on
Investment
Evidence increasingly suggests the cost-effectiveness of self-care and patient
engagement.
Modern consumer-patients want personalized medicine and have increasingly
employed technology platforms to achieve their goals. Moreover, patient use
of data about medical conditions, recommended courses of treatment, and
prices of services can have an impact on healthcare costs.
comScore (2011)15 Fifth Annual Online Marketing Effectiveness Benchmarks for
the Pharmaceutical Industry, March 2011
Potential legislation is likely to increase the responsibility of industry with
respect to the health care of its employees.
Industry has responded to these pressures by creating innovative wellness
programs.
These programs produce the dual benefit of improving employee health/morale
and reducing the corporate cost of health care per employee.
Palacio (2010)7 Benchmarking Electronic Medical Records Initiatives in the
U.S.: A Conceptual Model
Although EHRs seem to promise an extensive list of benefits, the inherent risk
and financial expenditure required to implement them are often absent from
the conversation.
Over the long term, advanced data capture can improve healthcare
effectiveness and efficiency through better resource allocation and reduction
in errors.
It has been suggested that vendors integrate EHRs by following the “network-of-
networks” model used by the banking industry in which banks allow
customers to access ATMs (and their accounts) from a variety of institutions.
In a 2008 study, Palacio and colleagues found that early adoption of healthcare
information technology is associated with improved financial performance.
Specifically, healthcare organizations with higher use of information
technology have increased revenue and profitability because of cost-savings
from improved efficiency and reduction in errors.
Still, the study warns that the data must complement clinical and business
processes, or the benefits could be limited.
Makower (2010)17 FDA impact on U.S. Medical Device Technology Innovation: A
Survey of Over 200 Medical Technology Companies
Entrepreneurs play the key role of connecting the dots between available data
and stakeholders who will use the data to promote community health and
disease prevention. Moreover, new technologies can extend the scope of
medicine to conditions once considered beyond its boundaries.
Antos (2009)4 Bending the Curve: Effective Steps to Address Long-term
Health Care Spending Growth
The healthcare industry’s use of data-driven innovation needs to be based on
modernized data systems, increased access to data, and implementation of
easy-to-use technology that will allow stakeholders to participate in achieving
desired health outcomes and cost reductions.
(continued on next page)
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Table 1. Overview of included studies (continued)
Study Title Overview of main study points
Hildreth (2009)8 Healthcare Electronic Records Technology and Government
Funding: Improving Patient Care? Beye Network
Despite assistance from the government, small and rural hospitals may have to
spend a few million dollars to buy and install new technology; larger hospitals
may have to spend much more.
But the smaller institutions with lesser resources may not have sufficient
volumes of patients to offset the initial investment spent in financing and
implementation. The time frame may be too long between initial outlay and
when such hospitals begin to realize savings from the investment, which is
likely to delay the needed investment.
Cohen (2009)12 The Cost-Savings and Cost-Effectiveness of Clinical
Preventive Care
Another advantage of EHRs is to provide data that can be used in CER, a
promising method to assess the relative value of treatments.
Specifically, this research can pinpoint treatments that are less effective for a
given condition and influence stakeholders to avoid prescribing or paying for
an approach that is not a good value overall.
Accordingly, CER can move into areas of medical uncertainty such as preventive
services and technology in order to identify patterns and then develop the
policies that influence them.
Carruth (2008)2 Accounting and Economic Implications of Healthcare
Information Technology
An interoperable data system can be accrued by various stakeholders and
highlight how integrated patient- and population-level data may lead to
personalized medicine.
However, existing challenges will require long-term commitment to
implementation.
Altering the traditions of medical practice to incorporate health information
technology will require a methodic revamping of the current system.
Consumers will need to understand the information and learn how to
electronically manage their personal medical records.
Hillestead (2005)1 Can Electronic Medical Record Systems Transform Health
Care? Potential Health Benefits, Savings, and Costs
After weighing the costs and benefits of EHR implementation, the process could
save more than $81 billion annually by improving healthcare efficiency and
safety.
In addition, data-enabled prevention and management of chronic disease may
potentially double those savings. Still, these developments will require further
change in the healthcare model.
ATM, automatic teller machine; CER, comparative-effectiveness research; EHR, electronic health record; FDA, U.S. Food and Drug Administration
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